{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:04:34Z","timestamp":1791317074807,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1102,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1038\/mt.2013.170","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T12:01:23Z","timestamp":1374753683000},"page":"1889-1897","source":"Crossref","is-referenced-by-count":192,"title":["Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector Nucleases"],"prefix":"10.1016","volume":"21","author":[{"given":"Kristie","family":"Bloom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Ely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Mussolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Cathomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Arbuthnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2013.170_bib1","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1038\/mt.2013.170_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J Hepatol"},{"key":"10.1038\/mt.2013.170_bib3","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1128\/JVI.69.6.3350-3357.1995","article-title":"The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes","volume":"69","author":"Newbold","year":"1995","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.170_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/317489a0","article-title":"The hepatitis B virus","volume":"317","author":"Tiollais","year":"1985","journal-title":"Nature"},{"key":"10.1038\/mt.2013.170_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2009.05.022","article-title":"Control of cccDNA function in hepatitis B virus infection","volume":"51","author":"Levrero","year":"2009","journal-title":"J Hepatol"},{"key":"10.1038\/mt.2013.170_bib6","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1128\/JVI.67.3.1218-1226.1993","article-title":"The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks","volume":"67","author":"Chen","year":"1993","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.170_bib7","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1128\/JVI.68.3.2026-2030.1994","article-title":"Woodchuck hepatitis virus X protein is required for viral infection in vivo","volume":"68","author":"Zoulim","year":"1994","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.170_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1440-1746.2000.02069.x","article-title":"Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK\/STAT pathways","volume":"15","author":"Arbuthnot","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1038\/mt.2013.170_bib9","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1365-2036.2011.04869.x","article-title":"Review article: current antiviral therapy of chronic hepatitis B","volume":"34","author":"Ayoub","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1038\/mt.2013.170_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2010.20","article-title":"Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs","volume":"18","author":"Cradick","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.170_bib11","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.1128\/JVI.00366-08","article-title":"Zinc finger proteins designed to specifically target duck hepatitis B virus covalently closed circular DNA inhibit viral transcription in tissue culture","volume":"82","author":"Zimmerman","year":"2008","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.170_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3486","article-title":"TALENs: a widely applicable technology for targeted genome editing","volume":"14","author":"Joung","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/mt.2013.170_bib13","doi-asserted-by":"crossref","first-page":"9283","DOI":"10.1093\/nar\/gkr597","article-title":"A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity","volume":"39","author":"Mussolino","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2013.170_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcv.2012.08.013","article-title":"First WHO International Reference Panel containing hepatitis B virus genotypes A-G for assays of the viral DNA","volume":"55","author":"Chudy","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1038\/mt.2013.170_bib15","doi-asserted-by":"crossref","first-page":"W117","DOI":"10.1093\/nar\/gks608","article-title":"TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction","volume":"40","author":"Doyle","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2013.170_bib16","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1128\/JVI.66.7.4107-4116.1992","article-title":"The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly","volume":"66","author":"Nassal","year":"1992","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.170_bib17","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1128\/JVI.62.8.2836-2844.1988","article-title":"Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions","volume":"62","author":"Sells","year":"1988","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.170_bib18","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1128\/JVI.02303-05","article-title":"Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells allows highly efficient replication and facilitates the study of early infection events","volume":"80","author":"Rabe","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.170_bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hep.21299","article-title":"Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients","volume":"44","author":"Laras","year":"2006","journal-title":"Hepatology"},{"key":"10.1038\/mt.2013.170_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nmeth.1456","article-title":"Transient cold shock enhances zinc-finger nuclease-mediated gene disruption","volume":"7","author":"Doyon","year":"2010","journal-title":"Nat Methods"},{"key":"10.1038\/mt.2013.170_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nbt.2501","article-title":"Efficient genome editing in zebrafish using a CRISPR-Cas system","volume":"31","author":"Hwang","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2013.170_bib22","doi-asserted-by":"crossref","first-page":"13825","DOI":"10.1073\/pnas.202398599","article-title":"Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection","volume":"99","author":"Yang","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.170_bib23","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1128\/JVI.69.10.6158-6169.1995","article-title":"High-level hepatitis B virus replication in transgenic mice","volume":"69","author":"Guidotti","year":"1995","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.170_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nmeth.2364","article-title":"TALENs and ZFNs are associated with different mutation signatures","volume":"10","author":"Kim","year":"2013","journal-title":"Nat Methods"},{"key":"10.1038\/mt.2013.170_bib25","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.1128\/JVI.00052-12","article-title":"Targeted DNA mutagenesis for the cure of chronic viral infections","volume":"86","author":"Schiffer","year":"2012","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.170_bib26","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s000180050372","article-title":"Homing endonucleases: structure, function and evolution","volume":"55","author":"Jurica","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"10.1038\/mt.2013.170_bib27","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1039\/c1cs15039a","article-title":"Artificial DNA cutters for DNA manipulation and genome engineering","volume":"40","author":"Aiba","year":"2011","journal-title":"Chem Soc Rev"},{"key":"10.1038\/mt.2013.170_bib28","doi-asserted-by":"crossref","first-page":"13136","DOI":"10.1128\/JVI.77.24.13136-13145.2003","article-title":"Chromosomal integration and homologous gene targeting by replication-incompetent vectors based on the autonomous parvovirus minute virus of mice","volume":"77","author":"Hendrie","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.170_bib29","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","article-title":"Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain","volume":"93","author":"Kim","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.170_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1038\/mt.2013.170_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","author":"Fu","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2013.170_bib32","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1128\/JVI.80.6.2797-2807.2006","article-title":"Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus","volume":"80","author":"Meuleman","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.170_bib33","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1128\/JVI.70.7.4567-4575.1996","article-title":"Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver","volume":"70","author":"Yang","year":"1996","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.170_bib34","doi-asserted-by":"crossref","first-page":"e1003065","DOI":"10.1371\/journal.pgen.1003065","article-title":"Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach","volume":"8","author":"Ding","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1038\/mt.2013.170_bib35","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1093\/nar\/gkr151","article-title":"Assembly of custom TALE-type DNA binding domains by modular cloning","volume":"39","author":"Morbitzer","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2013.170_bib36","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.170_bib37","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bbrc.2009.09.004","article-title":"Inhibition of hepatitis B virus replication with linear DNA sequences expressing antiviral micro-RNA shuttles","volume":"389","author":"Chattopadhyay","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2013.170_bib38","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/nar\/gkh599","article-title":"Mismatch cleavage by single-strand specific nucleases","volume":"32","author":"Till","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2013.170_bib39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.20353","article-title":"Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"10.1038\/mt.2013.170_bib40","first-page":"36","article-title":"Image Processing with ImageJ","volume":"11","author":"Abramoff","year":"2004","journal-title":"Biophotonics Int"},{"key":"10.1038\/mt.2013.170_bib41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/mt.2013.4","article-title":"Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases","volume":"21","author":"Tremblay","year":"2013","journal-title":"Mol Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616322559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616322559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T17:21:56Z","timestamp":1596216116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616322559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1525001616322559"],"URL":"https:\/\/doi.org\/10.1038\/mt.2013.170","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}